Share
- Release Date: 04/12/13 14:13
- Summary: GENERAL: EBO: Ebos ASX Listing Confirmed
- Price Sensitive: No
- Download Document 1.67KB
EBO
04/12/2013 12:13
GENERAL
REL: 1213 HRS Ebos Group Limited
GENERAL: EBO: Ebos ASX Listing Confirmed
EBOS ASX LISTING CONFIRMED
News release
December 2013
EBOS is pleased to confirm that the Company's application to list on the ASX
has been approved.
ASX has reserved 6 December 2013 as the listing date and trading is expected
to commence on or around that date under the code EBO. The Company's primary
listing will remain on the NZX.
EBOS Managing Director Mark Waller says the dual listing on the ASX will
facilitate the ability of Australian institutional and retail investors to
trade the Company's shares, deepening liquidity for the benefit of all
shareholders.
"The $1.1 billion acquisition of Symbion earlier this year transformed EBOS
into the largest diversified Australasian marketer, wholesaler and
distributor of healthcare, medical and pharmaceutical products by revenue and
a leading Australasian animal care products marketer, wholesaler and
distributor. Since this acquisition we have received increasing interest from
Australian investors who want to participate in the EBOS growth story."
EBOS gained further recognition for its determination to be the leading
player in the markets in which it operates with the accolade of the "Best
Growth Strategy" in the Deloitte Top 200 Awards announced last week.
"EBOS is delighted to receive recognition for its strategy which continues to
deliver exceptional performance for our shareholders amounting to compounding
returns of 19 per cent over the last 10 years," says Mr Waller.
Ends
Authorised for release
Dennis Doherty
CFO
EBOS Group Limited
DDI 03 339 5062
End CA:00244723 For:EBO Type:GENERAL Time:2013-12-04 12:13:50
